An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background: Canada implemented the legalization and regulation of non-medical cannabis use, production and sale in 2018 aiming to improve public health and safety. While outcomes from legalization reforms in other jurisdictions mostly rely on US-based data have been assessed to be mixed, Canadian data are only emerging. We compiled select population-level data on key indicators to gauge initial developments from pre- to post-legalization of cannabis in Canada. Methods: We examined indicators data focusing on the following topics: prevalence of cannabis use, frequency of use, methods/products of consumption, driving after cannabis use, and cannabis sourcing. Indicator data were obtained mostly from national and some provincial population surveys. Prevalence or percentages for the indicators pre- and post-legalization (e.g., 2017- 2020), including confidence intervals were reported, with changes noted, as available in and indicated by the data sources. Results: Data suggested selected increases in cannabis use prevalence, mostly among mid- and older- but possibly also younger (e.g., under legal use age) users. Frequency of use and driving after cannabis use among active users do not appear to have changed. Methods of cannabis use show diversifying trends, with decreases in smoking and increases in alternatives use modes (e.g., edibles, vaping). There is a clearly increasing trend towards accessing cannabis from legal sources among adults, while under-legal-use-age youth do not appear to experience heightened barriers to obtaining cannabis in legalization contexts. Conclusions: Preliminary indicators on cannabis legalization in Canada show a mixed picture, some similar to US-based developments. While some use increases are observed, these do not necessarily represent indications of increases in cannabis-related harm, also since key (e.g., hospitalization or injury) data are lacking to date. There is a gradual embracing of legal supply sources of cannabis among users, which can be expected to serve public health and safety objectives. At the same time, cannabis use and access among under-age users as a principally vulnerable group do not appear to be hindered or reduced by legalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vaping increased from 33% in 2018 to 36% in 2019 before decreasing to 31% in 2020, possibly in response to the outbreak of lung injuries in the United States linked to vaping adulterated cannabis oils [12, 25].”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the NCS, smoking was the most common way of using cannabis (65% in 2019 and 58% in 2020), followed by edible products (13 and 19%) and ‘vaping’ cannabis oils (13 and 12%).”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This marginally decreased from 80% in 2016/17 to 76% in 2018/2019.”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, increased cannabis‐related presentations may have been associated with increased testing and reporting [12, 13].”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since cannabis was legalized, fewer Canadian cannabis users report driving when they may be intoxicated.”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerdá, M., Mauro, C., Hamilton, A., Levy, N. S., Santaella-Tenorio, J., Hasin, D., Wall, M. M., Keyes, K. M., & Martins, S. S. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3254 · Cited by 598 · cited 1×
“The preliminary data on cannabis legalization from Canada reflect some similar developments from the US, for example in regards to select increases in use and diversification in use methods yet an absence in clear change trends for driving under the influence of cannabis in legalization settings [7, 40, 50].”
BackgroundLower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Self-citationLeung, J., Chan, G. C. K., Hides, L., & Hall, W. D. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106479 · Cited by 358
Self-citationHall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357 · cited 1×
“The largest amount of evidence on the impacts of legalization has been based on US data that have shown mixed results [5, 6].”
BackgroundSelf-citationSmart, R., & Pacula, R. L. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669626 · Cited by 305
Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.11.008 · Cited by 298 · cited 1×
“Third, there has been a steady diversification of modes of cannabis use and related cannabis products [40, 41].”
BackgroundSelf-citationAssessing the public health impacts of legalizing recreational cannabis use: the US experience
Hall, W., & Lynskey, M. (2020) · World Psychiatry · doi:10.1002/wps.20735 · Cited by 296 · cited 2×
“Legalization requires time to be fully implemented and its effects to be assessed, but assessments to emerge are unlikely to be unequivocal or conclusive [5, 15, 31].”
BackgroundSelf-citationChanging landscape of cannabis: novel products, formulations, and methods of administration
Spindle, T. R., Bonn-Miller, M. O., & Vandrey, R. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2019.04.002 · Cited by 259
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236 · cited 1×
“‘Lower-Risk Cannabis Use Guidelines’) mainly responsible for adverse public health impacts [53, 54].”
BackgroundPrevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets
Goodman, S., Wadsworth, E., Leos-Toro, C., & Hammond, D. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.102658 · Cited by 201 · cited 2×
“The preliminary data on cannabis legalization from Canada reflect some similar developments from the US, for example in regards to select increases in use and diversification in use methods yet an absence in clear change trends for driving under the influence of cannabis in legalization settings [7, 40, 50].”
Background
Research works printed but not linked: 4
- Ontario Cannabis Store. A Quarterly Review: October 1 - December 31, 2020. 2020.
- Ontario Cannabis Store. A Year in Review 2019-2020: Ontario’s first full year of legal cannabis operations 2020.
- Solomon R, Chamberlain E, Vandenberghe M. Canada's new Cannabis-related driving legislation: the elusive quest for an effective deterrent. Can Criminal Law Review. 2018;23(3):265–90.
- Statistics Canada. The retail cannabis market in Canada: a portrait of the first year. Statistics Canada; 2019.
Cited by
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Hall, W., Stjepanović, D., Dawson, D., & Leung, J. (2023) · Addiction · doi:10.1111/add.16274 · Cited by 112
“We identified a review [12] and a Canadian government report [15] that examined cannabis prices and markets.”
BackgroundInfluentialSelf-citationCannabis Vaping Among Youth and Young Adults: a Scoping Review
Harrell, M. B., Clendennen, S. L., Sumbe, A., Case, K. R., Mantey, D. S., & Swan, S. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00413-y · Cited by 88
The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review
Manthey, J., Jacobsen, B., Hayer, T., Kalke, J., López‐Pelayo, H., Pons-Cabrera, M. T., Verthein, U., & Rosenkranz, M. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104039 · Cited by 70
Myran, D. T., Friesen, E. L., Dickson, S. E., Konikoff, L., Arora, G., & Tanuseputro, P. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13650 · Cited by 56
Myran, D. T., Imtiaz, S., Konikoff, L., Douglas, L., & Elton‐Marshall, T. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13546 · Cited by 46
Metadata
- Authors
- Fischer, B., Lee, A., Robinson, T., & Hall, W.
- Affiliations
- Simon Fraser University (CA)
- The University of Queensland (AU)
- Corresponding author
- Fischer, Benedikt
- Venue
- Substance Abuse Treatment, Prevention, and Policy
- Published
- 2021-10-07
- Volume
- 16
- Issue
- 1
- Pages
- 77-77
- ISSN
- 1747-597X (ISSN-L)
- PMC
- PMC8496143
- OpenAlex
- W3202964586
- Semantic Scholar
- 1ce75ced1efb05f97059e8c301e11c7aaa2e2e36
- Cited by
- 52
- References
- 40
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 22 · 2022: 8
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Substance Abuse Treatment Prevention and Policy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- McMaster University
- King's College London
- University of Toronto
- Simon Fraser University
- Universidade de São Paulo
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- Department of Psychiatry, University of Toronto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- cannabis legalization, non-medical cannabis, cannabis use prevalence, cannabis consumption methods, edibles, vaping, youth cannabis use, cannabis regulation, Canada
- MeSH terms
- Adolescent, Adult, Canada, Cannabis, Humans, Legislation, Drug, Public Health, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An overview of select cannabis use and supply indicators pre- and post-legalization in Canada. https://app.cochat.ai/papers/10.1186/s13011-021-00405-7
- The paper
- Fischer, B., Lee, A., Robinson, T., & Hall, W. (2021). An overview of select cannabis use and supply indicators pre- and post-legalization in Canada. Substance Abuse Treatment, Prevention, and Policy. https://doi.org/10.1186/s13011-021-00405-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.